Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.247EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.181EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
CQ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
CH.1.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.185EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.329EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.342EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.90EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.169EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.528EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.175EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.483EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.181EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.113EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.594EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.328EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.145EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.284EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.3 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
R.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ML.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.283EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used